CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome: Moreover, given the high frequency of somatic CDH1 mutations in sporadic DGC, LCIS and LBC and their association with poor prognosis [51,52], these drugs may also be useful for the treatment of sporadic cancers.